Wildwood, MO, United States of America

Jon Philip Lawson

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Jon Philip Lawson

Introduction

Jon Philip Lawson, an inventive mind based in Wildwood, MO, has made significant contributions to the field of pharmaceutical sciences. With three patents to his name, Lawson is recognized for his innovative approaches in preparing compounds that showcase high chemical purity and enantiomeric excess.

Latest Patents

Lawson's latest patents reveal his focus on creating efficient methods for synthesizing prodrugs. The first patent outlines a method of preparing a DON prodrug from L-glutamic acid, emphasizing the preparation of the compound in greater than 95% chemical purity and enantiomeric excess. The second patent presents a similar method involving L-pyroglutamic acid, where the compound is again produced with remarkable purity and specific chemical characteristics. These advancements highlight his dedication to enhancing pharmaceutical formulations.

Career Highlights

Lawson's career has been marked by meaningful contributions to the pharmaceutical industry. He has worked with esteemed companies such as Dracen Pharmaceuticals, Inc. and Tetra Discovery Partners, LLC. His innovative spirit and practical approach to drug development have positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Lawson has collaborated with notable colleagues, including Robert Christian Wild and Yiyang Shao. These partnerships have fostered a productive environment for developing enhanced drug therapies and innovative compounds.

Conclusion

Jon Philip Lawson's innovative work and patents demonstrate his commitment to progress in pharmaceutical sciences. As he continues to explore and create, his contributions are likely to leave a lasting impact on the industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…